ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Alto Neuroscience Inc
32.00
+0.3200
1.01%
成交量:
41.57萬
成交額:
1,326.83萬
市值:
12.44億
市盈率:
-13.44
高:
33.13
開:
32.00
低:
31.11
收:
31.68
52周最高:
37.48
52周最低:
3.59
股本:
3,887.04萬
流通股本:
2,964.95萬
量比:
0.82
換手率:
1.40%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.3816
每股收益(LYR):
-2.1918
淨資產收益率:
-49.17%
總資產收益率:
-26.79%
市淨率:
5.67
市盈率(LYR):
-14.60
資料載入中...
總覽
公司
新聞
公告
美國研究綜述-愛彼迎、Five Below、Silgan Holdings
路透中文
·
08/13
美國研究綜述-愛彼迎、Five Below、Silgan Holdings
路透中文
·
08/13
Alto Neuroscience宣佈1億美元普通股註冊直接發行定價
环球市场播报
·
07/13
Alto Neuroscience公布1億美元普通股承銷註冊直接發行定價
美股速递
·
07/13
Alto Neuroscience計劃新增III期臨床試驗 加速並擴展Alto-207臨床開發進程 - SEC文件披露
美股速递
·
07/13
Alto Neuroscience股東擬轉售最多600萬股普通股 已提交SEC文件
美股速递
·
04/11
精神分裂症認知研究未達主要終點,Alto Neuroscience盤後重挫18.8%報19.01美元
美股速递
·
04/02
Alto Neuroscience成功研發Alto-101改良緩釋日服口服制劑,計劃尋求合作伙伴
美股速递
·
04/02
Alto Neuroscience Inc:概念驗證研究中,Alto-101未達到主要終點的統計學顯著性
美股速递
·
04/02
Alto Neuroscience Inc:Alto-207研發仍為公司首要任務;二期B階段試驗計劃於2026年上半年啓動
美股速递
·
04/02
Alto Neuroscience擬將募資用於支持難治性抑鬱症藥物Alto-207的研發
美股速递
·
03/16
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/ANRO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ANRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","market":"US","secType":"STK","nameCN":"Alto Neuroscience Inc","latestPrice":32,"timestamp":1789156800000,"preClose":31.68,"halted":0,"volume":415744,"delay":0,"changeRate":0.01010101010101011,"floatShares":29649500,"shares":38870376,"eps":-2.381577,"marketStatus":"盤前交易","change":0.32,"latestTime":"09-14 04:39:56 EDT","open":32,"high":33.1327,"low":31.11,"amount":13268345.0368,"amplitude":0.063848,"askPrice":51.2,"askSize":200,"bidPrice":18.4,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.381577,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"listingDate":1706850000000,"exchange":"NYSE","adjPreClose":32,"postHourTrading":{"tag":"盘后","latestPrice":32,"preClose":32,"latestTime":"19:30 EDT","volume":8310,"amount":265906.05,"timestamp":1789169408551,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8240772380978627,"impliedVol":0.9215,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANRO\",,,,,undefined,":{"symbol":"ANRO","floatShares":29649500,"roa":"-26.79%","roe":"-49.17%","lyrEps":-2.191806,"volumeRatio":0.8240772380978627,"shares":38870376,"dividePrice":0,"high":33.1327,"amplitude":0.063848,"preClose":31.68,"low":31.11,"week52Low":3.59,"pbRate":"5.67","week52High":37.48,"institutionHeld":0,"latestPrice":32,"committee":0.666667,"eps":-2.381577,"divideRate":0,"volume":415744,"delay":0,"ttmEps":-2.381577,"open":32,"prevYearClose":17.8,"prevWeekClose":32,"prevMonthClose":35.38,"prevQuarterClose":26.39,"fiveDayClose":36.4,"twentyDayClose":32.3,"sixtyDayClose":21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ANRO","fiscalQuarterEnding":"2026/06","expectedEps":-0.71,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-05-13","symbol":"ANRO","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2026-03-16","symbol":"ANRO","fiscalQuarterEnding":"2025/12","expectedEps":-0.56,"name":null,"time":"盤前","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ANRO","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2025-08-13","symbol":"ANRO","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6364,"buy":0.2727,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6364,"analysts":11,"updateTime":1786766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANRO","date":"2026-09-11","current":-13.436475,"percent":0.050553,"low":-17.068671,"twenty":-11.106858,"median":-6.950061,"eighty":-1.502667,"high":-0.793245,"avg":-6.645176,"sd":4.731353,"marketCap":1243189854},"quantilePoints":[{"date":"2024-02-09","current":-15.481605,"twenty":-16.048587,"median":-15.481605,"eighty":-13.872658,"marketCap":506867732},{"date":"2024-02-16","current":-12.96931,"twenty":-15.548491,"median":-13.234406,"eighty":-11.571235,"marketCap":424615224},{"date":"2024-02-23","current":-10.603839,"twenty":-15.481605,"median":-12.585941,"eighty":-11.026361,"marketCap":347169680},{"date":"2024-03-01","current":-12.56147,"twenty":-14.292343,"median":-12.488059,"eighty":-11.135662,"marketCap":411262544},{"date":"2024-03-08","current":-11.631595,"twenty":-13.230328,"median":-12.361629,"eighty":-11.293904,"marketCap":380818433},{"date":"2024-03-15","current":-12.153631,"twenty":-13.001937,"median":-12.137317,"eighty":-11.306955,"marketCap":397909864},{"date":"2024-03-22","current":-11.14409,"twenty":-12.949734,"median":-12.108768,"eighty":-11.306955,"marketCap":404586204},{"date":"2024-03-28","current":-12.415912,"twenty":-12.956259,"median":-12.145474,"eighty":-11.437463,"marketCap":450759680},{"date":"2024-04-05","current":-10.418119,"twenty":-12.920369,"median":-11.868143,"eighty":-11.162905,"marketCap":378229815},{"date":"2024-04-12","current":-10.440317,"twenty":-12.863272,"median":-11.793418,"eighty":-10.823597,"marketCap":379035702},{"date":"2024-04-19","current":-9.988964,"twenty":-12.713187,"median":-11.631595,"eighty":-10.532067,"marketCap":362649325},{"date":"2024-04-26","current":-10.455115,"twenty":-12.538631,"median":-11.566341,"eighty":-10.461035,"marketCap":379572960},{"date":"2024-05-03","current":-10.654895,"twenty":-12.497847,"median":-11.513206,"eighty":-10.478793,"marketCap":386825947},{"date":"2024-05-10","current":-10.802879,"twenty":-12.4592,"median":-11.360121,"eighty":-10.478793,"marketCap":392198529},{"date":"2024-05-17","current":-8.114957,"twenty":-12.377436,"median":-11.191128,"eighty":-10.431438,"marketCap":344382544},{"date":"2024-05-24","current":-7.443985,"twenty":-12.295701,"median":-11.079356,"eighty":-10.270134,"marketCap":315907856},{"date":"2024-05-31","current":-7.59948,"twenty":-12.254775,"median":-10.943138,"eighty":-9.999323,"marketCap":322506720},{"date":"2024-06-07","current":-7.453823,"twenty":-12.218885,"median":-10.773282,"eighty":-9.088414,"marketCap":316325341},{"date":"2024-06-14","current":-7.612146,"twenty":-12.153631,"median":-10.654895,"eighty":-8.114957,"marketCap":323044231},{"date":"2024-06-21","current":-6.997854,"twenty":-12.14058,"median":-10.580902,"eighty":-7.890353,"marketCap":296974938},{"date":"2024-06-28","current":-6.731872,"twenty":-12.125897,"median":-10.558705,"eighty":-7.854905,"marketCap":285687202},{"date":"2024-07-05","current":-7.35883,"twenty":-12.080219,"median":-10.514309,"eighty":-7.738804,"marketCap":312294007},{"date":"2024-07-12","current":-8.486086,"twenty":-11.912764,"median":-10.492111,"eighty":-7.738804,"marketCap":360132504},{"date":"2024-07-15","current":-8.840728,"twenty":-11.90384,"median":-10.492111,"eighty":-7.738804,"marketCap":375182817},{"date":"2024-08-02","current":-6.212575,"twenty":-11.894916,"median":-10.481012,"eighty":-7.674208,"marketCap":263649243},{"date":"2024-08-09","current":-5.762939,"twenty":-11.86488,"median":-10.440317,"eighty":-7.584281,"marketCap":244567596},{"date":"2024-08-16","current":-5.077305,"twenty":-11.842621,"median":-10.421819,"eighty":-7.439715,"marketCap":252875166},{"date":"2024-08-23","current":-5.770157,"twenty":-11.798049,"median":-10.270134,"eighty":-7.320833,"marketCap":287382652},{"date":"2024-08-30","current":-6.766131,"twenty":-11.747422,"median":-10.066655,"eighty":-7.023186,"marketCap":336987162},{"date":"2024-09-06","current":-6.885215,"twenty":-11.696849,"median":-9.985264,"eighty":-6.997854,"marketCap":342918136},{"date":"2024-09-13","current":-7.036776,"twenty":-11.629964,"median":-9.589405,"eighty":-7.005638,"marketCap":350466649},{"date":"2024-09-20","current":-7.269531,"twenty":-11.615282,"median":-8.800669,"eighty":-7.041657,"marketCap":362059007},{"date":"2024-09-27","current":-6.495486,"twenty":-11.576129,"median":-8.327763,"eighty":-6.997854,"marketCap":323507676},{"date":"2024-10-04","current":-5.51575,"twenty":-11.542663,"median":-8.073812,"eighty":-6.792939,"marketCap":274711934},{"date":"2024-10-11","current":-6.392641,"twenty":-11.505807,"median":-7.947789,"eighty":-6.506312,"marketCap":318385471},{"date":"2024-10-18","current":-7.724215,"twenty":-11.453451,"median":-7.863613,"eighty":-6.586066,"marketCap":384704544},{"date":"2024-10-25","current":-2.23553,"twenty":-11.361501,"median":-7.821648,"eighty":-6.506312,"marketCap":111340558},{"date":"2024-10-31","current":-2.181401,"twenty":-11.357822,"median":-7.776801,"eighty":-6.403467,"marketCap":108644661},{"date":"2024-11-08","current":-2.083968,"twenty":-11.223755,"median":-7.738804,"eighty":-6.212575,"marketCap":103792046},{"date":"2024-11-15","current":-2.159604,"twenty":-11.191128,"median":-7.724215,"eighty":-6.11117,"marketCap":124062772},{"date":"2024-11-22","current":-1.92017,"twenty":-11.14409,"median":-7.634377,"eighty":-5.98126,"marketCap":110307987},{"date":"2024-11-29","current":-2.070403,"twenty":-11.113816,"median":-7.615312,"eighty":-5.768005,"marketCap":118938440},{"date":"2024-12-06","current":-1.830969,"twenty":-11.06322,"median":-7.574148,"eighty":-5.648645,"marketCap":105183655},{"date":"2024-12-13","current":-1.798105,"twenty":-11.000259,"median":-7.504253,"eighty":-5.44863,"marketCap":103295743},{"date":"2024-12-20","current":-1.746462,"twenty":-10.916697,"median":-7.443985,"eighty":-5.07514,"marketCap":100329024},{"date":"2024-12-27","current":-2.075098,"twenty":-10.841355,"median":-7.436869,"eighty":-2.363274,"marketCap":119208142},{"date":"2025-01-03","current":-2.056319,"twenty":-10.79104,"median":-7.390494,"eighty":-2.255016,"marketCap":118129335},{"date":"2025-01-10","current":-2.070403,"twenty":-10.767363,"median":-7.35883,"eighty":-2.165554,"marketCap":118938440},{"date":"2025-01-17","current":-2.079793,"twenty":-10.725927,"median":-7.312287,"eighty":-2.141345,"marketCap":119477844},{"date":"2025-01-24","current":-2.272279,"twenty":-10.654895,"median":-7.277651,"eighty":-2.138097,"marketCap":130535613},{"date":"2025-01-31","current":-2.093877,"twenty":-10.603839,"median":-7.253293,"eighty":-2.122046,"marketCap":120286949},{"date":"2025-02-07","current":-1.854443,"twenty":-10.580902,"median":-7.17813,"eighty":-2.093877,"marketCap":106532163},{"date":"2025-02-14","current":-1.530502,"twenty":-10.558705,"median":-7.145034,"eighty":-2.075098,"marketCap":87922747},{"date":"2025-02-21","current":-1.464775,"twenty":-10.529107,"median":-7.061183,"eighty":-2.070403,"marketCap":84146924},{"date":"2025-02-28","current":-1.305152,"twenty":-10.515789,"median":-6.997854,"eighty":-2.041295,"marketCap":74977067},{"date":"2025-03-07","current":-1.854443,"twenty":-10.50839,"median":-6.933931,"eighty":-2.023455,"marketCap":106532163},{"date":"2025-03-14","current":-1.483554,"twenty":-10.495071,"median":-6.768,"eighty":-2.01289,"marketCap":85225730},{"date":"2025-03-21","current":-1.180996,"twenty":-10.492111,"median":-6.549615,"eighty":-1.993408,"marketCap":72549751},{"date":"2025-03-28","current":-1.062067,"twenty":-10.474353,"median":-6.422411,"eighty":-1.971812,"marketCap":65243830},{"date":"2025-04-04","current":-0.81528,"twenty":-10.458075,"median":-6.392641,"eighty":-1.92017,"marketCap":50083438},{"date":"2025-04-11","current":-0.903418,"twenty":-10.443277,"median":-6.253891,"eighty":-1.873222,"marketCap":55497864},{"date":"2025-04-17","current":-0.991556,"twenty":-10.440317,"median":-6.19297,"eighty":-1.833785,"marketCap":60912290},{"date":"2025-04-25","current":-1.004777,"twenty":-10.431438,"median":-6.11117,"eighty":-1.798105,"marketCap":61724454},{"date":"2025-05-02","current":-1.079695,"twenty":-10.421079,"median":-6.037568,"eighty":-1.742706,"marketCap":66326716},{"date":"2025-05-09","current":-0.965115,"twenty":-10.40924,"median":-5.975847,"eighty":-1.645994,"marketCap":59287962},{"date":"2025-05-16","current":-1.041186,"twenty":-10.323409,"median":-5.766106,"eighty":-1.583083,"marketCap":65785273},{"date":"2025-05-23","current":-1.255422,"twenty":-10.270134,"median":-5.686944,"eighty":-1.500455,"marketCap":79321337},{"date":"2025-05-30","current":-1.152589,"twenty":-10.199102,"median":-5.617282,"eighty":-1.480737,"marketCap":72824027},{"date":"2025-06-06","current":-1.019763,"twenty":-10.071835,"median":-5.469741,"eighty":-1.461958,"marketCap":64431667},{"date":"2025-06-13","current":-1.049756,"twenty":-10.02004,"median":-5.30697,"eighty":-1.408438,"marketCap":66326716},{"date":"2025-06-20","current":-0.972631,"twenty":-9.987484,"median":-5.077305,"eighty":-1.322054,"marketCap":61453732},{"date":"2025-06-27","current":-0.985485,"twenty":-9.980084,"median":-2.492642,"eighty":-1.263991,"marketCap":62265896},{"date":"2025-07-03","current":-1.006909,"twenty":-9.974165,"median":-2.341082,"eighty":-1.221144,"marketCap":63619503},{"date":"2025-07-11","current":-1.105457,"twenty":-9.589405,"median":-2.272279,"eighty":-1.163435,"marketCap":69846092},{"date":"2025-07-18","current":-1.233999,"twenty":-8.963166,"median":-2.213594,"eighty":-1.13545,"marketCap":77967731},{"date":"2025-07-25","current":-1.319693,"twenty":-8.840728,"median":-2.178383,"eighty":-1.148304,"marketCap":83382157},{"date":"2025-08-01","current":-1.315408,"twenty":-8.760609,"median":-2.161951,"eighty":-1.152589,"marketCap":83111436},{"date":"2025-08-08","current":-1.311123,"twenty":-8.486086,"median":-2.154336,"eighty":-1.163435,"marketCap":82840714},{"date":"2025-08-15","current":-1.302504,"twenty":-8.327763,"median":-2.124393,"eighty":-1.163435,"marketCap":84479082},{"date":"2025-08-22","current":-1.498714,"twenty":-8.182106,"median":-2.122046,"eighty":-1.165443,"marketCap":97205098},{"date":"2025-08-29","current":-1.590557,"twenty":-8.114957,"median":-2.098572,"eighty":-1.169728,"marketCap":103161956},{"date":"2025-09-05","current":-1.465317,"twenty":-8.049126,"median":-2.084227,"eighty":-1.178742,"marketCap":95038967},{"date":"2025-09-12","current":-1.640654,"twenty":-7.979964,"median":-2.075098,"eighty":-1.18912,"marketCap":106411151},{"date":"2025-09-19","current":-1.715798,"twenty":-7.951589,"median":-2.070403,"eighty":-1.198007,"marketCap":111284945},{"date":"2025-09-26","current":-1.586383,"twenty":-7.904286,"median":-2.056319,"eighty":-1.216859,"marketCap":102891190},{"date":"2025-10-03","current":-1.841039,"twenty":-7.881184,"median":-2.039887,"eighty":-1.228,"marketCap":119407933},{"date":"2025-10-10","current":-2.513164,"twenty":-7.867586,"median":-2.056319,"eighty":-1.233142,"marketCap":163001306},{"date":"2025-10-17","current":-2.454718,"twenty":-7.85227,"median":-2.070403,"eighty":-1.244282,"marketCap":159210578},{"date":"2025-10-24","current":-4.667305,"twenty":-7.827138,"median":-2.075098,"eighty":-1.253708,"marketCap":302716712},{"date":"2025-10-31","current":-5.978158,"twenty":-7.812987,"median":-2.084227,"eighty":-1.2897,"marketCap":387737327},{"date":"2025-11-07","current":-4.646431,"twenty":-7.783605,"median":-2.103267,"eighty":-1.301657,"marketCap":301362880},{"date":"2025-11-14","current":-4.738274,"twenty":-7.773873,"median":-2.122046,"eighty":-1.304622,"marketCap":307319739},{"date":"2025-11-21","current":-7.060871,"twenty":-7.758215,"median":-2.12674,"eighty":-1.306199,"marketCap":439588640},{"date":"2025-11-28","current":-6.91117,"twenty":-7.745076,"median":-2.154336,"eighty":-1.306688,"marketCap":430268739},{"date":"2025-12-05","current":-6.67664,"twenty":-7.738804,"median":-2.161951,"eighty":-1.306839,"marketCap":415667562},{"date":"2025-12-12","current":-7.325342,"twenty":-7.736546,"median":-2.178383,"eighty":-1.309247,"marketCap":456053797},{"date":"2025-12-19","current":-9.705579,"twenty":-7.761946,"median":-2.213594,"eighty":-1.311015,"marketCap":604240215},{"date":"2025-12-26","current":-9.920149,"twenty":-7.817318,"median":-2.253904,"eighty":-1.311123,"marketCap":617598739},{"date":"2026-01-02","current":-8.882226,"twenty":-7.875492,"median":-2.303191,"eighty":-1.311123,"marketCap":552980763},{"date":"2026-01-09","current":-7.929133,"twenty":-7.944058,"median":-2.354526,"eighty":-1.311807,"marketCap":493644063},{"date":"2026-01-16","current":-8.493005,"twenty":-8.098499,"median":-2.410079,"eighty":-1.314542,"marketCap":528749021},{"date":"2026-01-23","current":-8.572845,"twenty":-8.233524,"median":-2.467243,"eighty":-1.314542,"marketCap":533719635},{"date":"2026-01-30","current":-7.644703,"twenty":-8.248494,"median":-2.550736,"eighty":-1.315408,"marketCap":475936252},{"date":"2026-02-06","current":-7.040911,"twenty":-8.233524,"median":-2.675047,"eighty":-1.315408,"marketCap":438345986},{"date":"2026-02-13","current":-8.203584,"twenty":-8.278435,"median":-4.258185,"eighty":-1.315408,"marketCap":510730547},{"date":"2026-02-20","current":-9.730529,"twenty":-8.329873,"median":-4.59216,"eighty":-1.315408,"marketCap":605793532},{"date":"2026-02-27","current":-9.625739,"twenty":-8.433125,"median":-4.619295,"eighty":-1.315408,"marketCap":599269602},{"date":"2026-03-06","current":-10.26945,"twenty":-8.504981,"median":-4.688178,"eighty":-1.318836,"marketCap":639345174},{"date":"2026-03-13","current":-11.092803,"twenty":-8.596797,"median":-4.780021,"eighty":-1.319693,"marketCap":690604627},{"date":"2026-03-20","current":-10.997993,"twenty":-8.80207,"median":-5.077305,"eighty":-1.323121,"marketCap":684702023},{"date":"2026-03-27","current":-10.5175,"twenty":-8.978914,"median":-5.159821,"eighty":-1.327405,"marketCap":665105643},{"date":"2026-04-02","current":-11.825873,"twenty":-9.157675,"median":-5.286907,"eighty":-1.342565,"marketCap":747844529},{"date":"2026-04-10","current":-11.315658,"twenty":-9.59795,"median":-5.418318,"eighty":-1.358364,"marketCap":715579558},{"date":"2026-04-17","current":-14.44502,"twenty":-9.715559,"median":-5.499511,"eighty":-1.373177,"marketCap":913474169},{"date":"2026-04-24","current":-14.251015,"twenty":-9.940109,"median":-5.617282,"eighty":-1.380269,"marketCap":901205714},{"date":"2026-05-01","current":-14.2233,"twenty":-9.993374,"median":-5.686437,"eighty":-1.40625,"marketCap":899453077},{"date":"2026-05-08","current":-13.341966,"twenty":-10.092797,"median":-5.762939,"eighty":-1.428579,"marketCap":843719235},{"date":"2026-05-15","current":-11.128225,"twenty":-10.269724,"median":-5.815711,"eighty":-1.431919,"marketCap":826893924},{"date":"2026-05-22","current":-10.161169,"twenty":-10.270134,"median":-5.928061,"eighty":-1.443182,"marketCap":755035825},{"date":"2026-05-29","current":-9.538479,"twenty":-10.26986,"median":-5.978158,"eighty":-1.454447,"marketCap":708766220},{"date":"2026-06-05","current":-9.448849,"twenty":-10.241369,"median":-6.015388,"eighty":-1.46008,"marketCap":702106201},{"date":"2026-06-12","current":-10.121163,"twenty":-10.184016,"median":-6.089518,"eighty":-1.46008,"marketCap":752063134},{"date":"2026-06-18","current":-10.291187,"twenty":-10.191631,"median":-6.176125,"eighty":-1.461019,"marketCap":764696952},{"date":"2026-06-26","current":-11.948923,"twenty":-10.281083,"median":-6.203076,"eighty":-1.464883,"marketCap":887876682},{"date":"2026-07-02","current":-11.778899,"twenty":-10.355847,"median":-6.327685,"eighty":-1.465317,"marketCap":875242863},{"date":"2026-07-10","current":-13.05408,"twenty":-10.419151,"median":-6.392641,"eighty":-1.474164,"marketCap":969996501},{"date":"2026-07-17","current":-14.296657,"twenty":-10.441725,"median":-6.422411,"eighty":-1.474164,"marketCap":1062327376},{"date":"2026-07-24","current":-14.045563,"twenty":-10.492111,"median":-6.506979,"eighty":-1.478859,"marketCap":1043669595},{"date":"2026-07-31","current":-14.976703,"twenty":-10.518342,"median":-6.61177,"eighty":-1.482615,"marketCap":1112858864},{"date":"2026-08-07","current":-14.893005,"twenty":-10.61405,"median":-6.65169,"eighty":-1.485663,"marketCap":1106639604},{"date":"2026-08-14","current":-15.04689,"twenty":-10.749604,"median":-6.68163,"eighty":-1.487837,"marketCap":1267519959},{"date":"2026-08-21","current":-15.955294,"twenty":-10.831771,"median":-6.749002,"eighty":-1.49576,"marketCap":1344042062},{"date":"2026-08-28","current":-16.910282,"twenty":-10.954971,"median":-6.885215,"eighty":-1.498499,"marketCap":1424488375},{"date":"2026-09-04","current":-16.956867,"twenty":-11.008887,"median":-6.91117,"eighty":-1.501609,"marketCap":1428412585},{"date":"2026-09-11","current":-14.758065,"twenty":-11.106858,"median":-6.950061,"eighty":-1.502667,"marketCap":1243189854}],"updateTime":1789375196571},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANRO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659713954","title":"美國研究綜述-愛彼迎、Five Below、Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659713954","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659713954?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 14:50","pubTimestamp":1786603808,"startTime":"0","endTime":"0","summary":"美国研究综述-爱彼迎、Five Below、Silgan Holdings路透8月13日-周四,华尔街证券分析师下调了多家在美国上市公司的评级和目标股价,其中包括爱彼迎、Five Below和Silgan Holdings。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4S44A0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRZ","ARMK","OI","INSW","CYTK","SRRK","SLGN","FLY","RHP","LOW","FIVE","NURE","CSCO","ELIS","ANRO","FLYT","LLII","TRAX","Z","HP","COHR","MNSH","OZEM","PAYX","ALGM","OSCR","DUOL","PTCT","ZG","LLY","ACM","LQDA","CAH","OII","SPHR","CURE","AMTM","KURA","ABNB","MNPR","PARK","EAT","UNCY","INO","YELP","MSGE","MTSI","BOAT","TRIP","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659139540","title":"美國研究綜述-愛彼迎、Five Below、Silgan Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659139540","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659139540?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 14:50","pubTimestamp":1786603808,"startTime":"0","endTime":"0","summary":"美国研究综述-爱彼迎、Five Below、Silgan Holdings路透8月13日-周四,华尔街证券分析师下调了多家在美国上市公司的评级和目标股价,其中包括爱彼迎、Five Below和Silgan Holdings。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4T44A0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HP","IHE","INO","OI","LQDA","INSW","PTCT","LOW","MTSI","LLY","IXJ","MNPR","COHX","MSGE","ZG","ABNB","SLGN","CSCO","RHP","UNCY","SPHR","YELP","TRIP","KURA","ALGM","AGNG","XES","EAT","TRAX","HRTS","FIVE","FLY","OII","PARK","AMTM","OSCR","ANRO","AMRZ","ARMK","ACM","MNSH","TRUH","ILDR","CAH","Z","PAYX","CYTK","COHR","DUOL","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117211","title":"Alto Neuroscience宣佈1億美元普通股註冊直接發行定價","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117211","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117211?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:40","pubTimestamp":1783946400,"startTime":"0","endTime":"0","summary":"临床阶段生物制药公司Alto Neuroscience近日宣布,已确定其承销注册直接发行的定价。此次发行共计3,776,436股普通股,每股价格为26.48美元,预计总募资额约为1亿美元。 Alto Neuroscience表示,此次募资所得款项,连同现有现金及现金等价物,将用于加速和扩展其核心候选药物ALTO-207的临床开发,包括计划开展一项针对难治性抑郁症的额外3期临床试验,其余部分将用于一般营运资金。近期股价信息显示,本次26.48美元的发行价接近其52周高点28.44美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-13/doc-inihsita5718384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161540568","title":"Alto Neuroscience公布1億美元普通股承銷註冊直接發行定價","url":"https://stock-news.laohu8.com/highlight/detail?id=1161540568","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161540568?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:49","pubTimestamp":1783943352,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc (ANRO) 公布了其普通股承销注册直接发行的定价细节,此次发行规模达1亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129847437","title":"Alto Neuroscience計劃新增III期臨床試驗 加速並擴展Alto-207臨床開發進程 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1129847437","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129847437?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:43","pubTimestamp":1783942998,"startTime":"0","endTime":"0","summary":"根据提交至美国证券交易委员会(SEC)的文件显示,Alto Neuroscience Inc(ANRO)正计划通过新增一项III期临床试验,以加速并扩展其候选药物Alto-207的临床开发项目。此举旨在进一步评估该药物在目标适应症中的疗效与安全性,标志着公司推进其核心管线的重要战略步骤。新的试验计划预计将丰富临床数据包,为后续的监管沟通与潜在商业化奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139073211","title":"Alto Neuroscience股東擬轉售最多600萬股普通股 已提交SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1139073211","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139073211?lang=zh_tw&edition=fundamental","pubTime":"2026-04-11 04:03","pubTimestamp":1775851392,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会(SEC)的文件显示,Alto Neuroscience Inc的部分现有股东计划转售公司普通股,总规模最高达600万股。\n此次股票转售方案涉及二级市场交易,出售方为现有持股股东。文件未披露具体售股股东身份及售股时间表,但明确本次转售不会为公司带来任何融资收益。\n市场分析人士指出,此类股东减持行为通常需要关注其背后的动机,可能是投资组合调整、资金需求或对公司前景的判断。投资者应密切关注后续披露的售股细节及公司基本面变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133009356","title":"精神分裂症認知研究未達主要終點,Alto Neuroscience盤後重挫18.8%報19.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133009356","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133009356?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 04:35","pubTimestamp":1775075712,"startTime":"0","endTime":"0","summary":"在备受瞩目的精神分裂症认知功能研究宣告未能达到主要临床终点后,生物制药公司Alto Neuroscience Inc(ANRO)股价在延长交易时段遭遇重挫,大幅下跌18.8%,最终报收于19.01美元。这一关键临床试验结果的失利,无疑给投资者对该公司核心管线前景的预期带来了显著冲击。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167468244","title":"Alto Neuroscience成功研發Alto-101改良緩釋日服口服制劑,計劃尋求合作伙伴","url":"https://stock-news.laohu8.com/highlight/detail?id=1167468244","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167468244?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 04:32","pubTimestamp":1775075578,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc宣布已成功开发出Alto-101的改良缓释型每日一次口服制剂。该突破性进展显著提升了用药便利性,公司表示将积极寻求该制剂版本的商业化合作机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164690093","title":"Alto Neuroscience Inc:概念驗證研究中,Alto-101未達到主要終點的統計學顯著性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164690093","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164690093?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 04:31","pubTimestamp":1775075475,"startTime":"0","endTime":"0","summary":"在一项概念验证研究中,Alto Neuroscience Inc (ANRO) 宣布,其候选药物Alto-101未能达到研究预设的主要终点的统计学显著性。这一结果意味着,在该研究的主要评估指标上,Alto-101与对照组相比,未显示出具有统计学意义的差异。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172191634","title":"Alto Neuroscience Inc:Alto-207研發仍為公司首要任務;二期B階段試驗計劃於2026年上半年啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1172191634","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172191634?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 04:31","pubTimestamp":1775075471,"startTime":"0","endTime":"0","summary":"Alto Neuroscience Inc 宣布,其核心候选药物Alto-207的研发工作依然是公司的重中之重。目前,该药物的二期B阶段临床试验正按计划推进,预计将于2026年上半年正式启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114948377","title":"Alto Neuroscience擬將募資用於支持難治性抑鬱症藥物Alto-207的研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1114948377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114948377?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 19:05","pubTimestamp":1773659132,"startTime":"0","endTime":"0","summary":"生物制药企业Alto Neuroscience宣布,计划将近期融资所得款项专项投入其核心管线药物Alto-207的临床开发。该药物主要针对现有疗法效果不佳的难治性抑郁症患者群体,目前正处于关键研究阶段。公司表示,此项资金部署将加速推进Alto-207的临床试验进程,有望为全球数百万耐药性抑郁症患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANRO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}